Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) traded up 0.7% during mid-day trading on Monday . The company traded as high as GBX 35.50 ($0.45) and last traded at GBX 35.48 ($0.45). 383,908 shares traded hands during mid-day trading, a decline of 46% from the average session volume of 714,286 shares. The stock had previously closed at GBX 35.25 ($0.44).
Creo Medical Group Trading Up 0.7 %
The firm has a market capitalization of £128.25 million, a price-to-earnings ratio of -322.55 and a beta of 0.86. The company has a fifty day moving average price of GBX 35.44 and a 200-day moving average price of GBX 36.28. The company has a current ratio of 4.13, a quick ratio of 2.19 and a debt-to-equity ratio of 13.33.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Read More
- Five stocks we like better than Creo Medical Group
- How to Use the MarketBeat Excel Dividend Calculator
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Value Stocks You Can Buy Before They Become Big
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
